title: Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
authors.affiliation: Department of Dermatology, University of Florida, Gainesville. Electronic address: mlongo@dermatology.med.ufl.edu.
authors.forename: Maria Isabel
authors.initials: MI
authors.lastname: Longo
authors.affiliation: Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville.
authors.forename: Xuerong
authors.initials: X
authors.lastname: Wen
authors.affiliation: Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville.
authors.forename: Karl L
authors.initials: KL
authors.lastname: Womer
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects*; D020123:Sirolimus / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000453:epidemiology*; D066027:Transplant Recipients / Q000706:statistics & numerical data*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus